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Abstract Resveratrol exerts several pharmacological
activities, including anti-cancer, anti-inflammatory, car-
dioprotective, or antioxidant effects. However, due to its
occurrence in plants more in glycosidic form as piceid, the
bioavailability and bioactivity are limited. The enzymatic
potential of probiotics for the transformation of piceid to
resveratrol was elucidated. Cell extract from Bifidobacteria
(B.) infantis, B. bifidum, Lactobacillus (L.) casei, L. plan-
tarum, and L. acidophilus was evaluated for their effect in
this bioconversion using high-performance liquid chro-
matography (HPLC) as analytical tool. Cell extract of B.
infantis showed the highest effect on the deglycosylation of
piceid to resveratrol, already after 30 min. Cell extracts of
all other tested strains showed a significant biotransfor-
mation with no further metabolization of resveratrol. The
conversion of piceid to resveratrol is of importance to
increase bioavailability and bioactivity as shown for anti-
inflammation in this study. Cell extracts from probiotics,
especially from B. infantis, may be added to piceid con-
taining products, for achieving higher biological effects
caused by the bioactivity of resveratrol or by health pro-
moting of the probiotics. These findings open a new per-
spective of novel combination of cell extracts from
probiotics and piceid, in health-promoting pharmaceutical
and food products.
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Introduction
Resveratrol (3,5,40-trihydroxystilbene) belongs to the group
of plant polyphenols (stilbenes), found naturally in the
grape skin and seeds, wine, berries, and medicinal plants,
such as Polygonum cuspidatum [1, 2]. Several health
benefits related to resveratrol, especially red-wine con-
sumption, have been documented, such as protective effect
against cancer, anti-inflammatory effect, cardiovascular
protection, antioxidant activity, and inhibition of platelet
aggregation [3–7]. Trans-resveratrol comes together with
the less studied cis-resveratrol which occurs in a much
smaller amount and has a similar biological effect [8–10].
In edible plants parts like grapes, including juices and
wine, resveratrol occurs mainly in the glycosidic form,
resveratrol-3-O-b-D glucoside, called piceid or polydatin
(Fig. 1), which is present to a greater extent than resvera-
trol [10]. In grape juice, the concentration of piceid is
around seven times higher than that of resveratrol and in
cocoa, milk chocolate, and dark chocolate, the amount of
piceid is four and five times higher than resveratrol,
respectively [11]. Due to the lower bioactivity and
bioavailability of piceid compared with resveratrol, the
deglycosylation step is of high interest for developing
bioactive products [12, 13].
The hydrolysis of piceid to resveratrol has been studied
using the chemical techniques with acid and alkaline
treatment [14] or by enzymatic conversion using crude
fungal enzyme preparations [2, 15] or purified b-glucosi-
dase from Aspergillus oryzae [2, 16], Aspergillus niger,
yeast [17], or snailase [18]. Enzymes from probiotics, such
as Bifidobacterium spp., showed the ability to deglycosy-
late isoflavone-glycosides, anthocyanin-glycoside, and
quercetin-glucosides [19–21]. However, according to the
best of our knowledge, no studies have been reported on
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the use of probiotics for the hydrolysis of piceid. The
activity of hydrolases, such as glucosidase or rhamnosi-
dase, is specific to the substrate, which means that the
enzymes do not cleave the same sugar moiety from dif-
ferent aglycones to the same extent [22, 23]. Thus, the
efficiency of the respective bioconversion has to be tested
for each polyphenol-glucoside.
The bioconversion of piceid by probiotics would have
several advantages, including receiving a safe product and
a less expensive production compared with enzymatic
(pure enzymes) and chemical hydrolysis. Furthermore,
probiotics may colonize the gut microflora, thus providing
a continuous system for deglycosylation in the human gut
and exert additional health benefits [24].
The aim of this study was to evaluate the effect of five
different probiotic cell extracts on the hydrolysis of trans-
piceid to trans-resveratrol. The increase of bioactivity was
confirmed in an anti-inflammatory in vivo test system.
Materials and methods
Chemicals, reagents, and bacterial strains
Piceid, resveratrol, Bradford reagent, p-nitrophenyl-b-D-
glucopyranoside (p-NPG), and further chemicals were
obtained from Sigma-Aldrich (St. Louis, MO, USA). Bifi-
dobacterium (B.) infantis (UV16PR) was kindly provided
by Medipharm (Ka˚gero¨d, Sweden), B. bifidum (BB12),
Lactobacillus (L.) acidophilus (LA-5), and L. plantarum
(ATCC 15697) were obtained from Christian Hansen A/S
(Hørsholm, Denmark) and Lactobacillus casei 160 from
Wiesby (Germany). Lyophylized cells of Bifidobacterium
spp. were activated and grown in Reinforced Clostridial
Medium (RCM, Oxoid Ltd., Hampshire, UK), while Lac-
tobacillus spp. was activated and grown in De Man,
Rogosa, and Sharpe broth (MRS, Oxoid Ltd., Hampshire,
UK).
b-Glucosidase activity assay
After the fourth subculture, cells were harvested by cen-
trifugation (10,0009g, 4 C, 10 min) and washed twice
with 50 mM phosphate buffer pH 6.5. The cells were
resuspended in the same buffer and mixed with glass beads
(200–300 lm) to perform mechanical disruption of cells by
mixing in five cycles, 2 min each with breaks on ice in
between [25]. Then, the suspension was centrifuged
(17,0009g, 30 min, 4 C) to remove the cell debris and
glass beads. The supernatant was then filtered through
0.45 lm filter (Merck Millipore, Darmstadt, Germany) and
used for enzyme activity assays.
b-Glucosidase activity was determined according to the
method described previously with minor modifications
[25]. Briefly, 150 lL of 5 mM p-NPG in 50 mM phosphate
buffer pH 6.5 were mixed with 600 lL of the appropriate
dilutions of cell-free extract and incubated at 37 C. The
reaction was stopped on ice by adding 375 lL of cold
0.1 M NaOH. The amount of p-nitrophenol released from
the reaction was measured at 410 nm with a Hitachi
U-1100 spectrophotometer (Hitachi Ltd. Tokyo, Japan).
The enzyme activity was expressed in Units (U), which
defined the amount of p-nitrophenol released from the
above reaction per ml per min (with a protein concentration
of the cell extract of 1 mg/ml), under the reaction condi-
tions. The protein content was determined using Bradford
reagent [26] and bovine serum albumin (BSA) as standard.
Optical density of the reaction mixture was read at 595 nm.
Bioconversion of piceid by ß-glucosidase
from probiotics
Bioconversion of piceid was carried out with cell extracts
of Bifidobacterium spp. and Lactobacillus spp. Enzymatic
hydrolysis of piceid was performed in triplicate by mixing
200 lL of 0.3 mM piceid in 50 mM phosphate buffer, pH
6.5, and 200 lL of cell-free extract. The stability of piceid
was determined in the control samples prepared by mixing
200 lL of 0.3 mM piceid in 50 mM phosphate buffer pH
6.5 and 200 lL of 50 mM phosphate buffer pH 6.5. The
negative control samples were prepared without piceid
(200 lL of phosphate buffer pH 6.5 and 200 lL of cell-
free enzyme). Reaction mixtures were incubated at 37 C
for up to 24 h. The bioconversion of piceid and, thus, the
formation of resveratrol were determined after different
incubation times, at the baseline (time 0 h), after 30 min, 2,
Fig. 1 Structure and RP-HPLC chromatogram recorded at 305 nm
showing piceid after incubation with enzymes of L. plantarum for
24 h at 37 C; peak 1 (retention time of 12.1 min) corresponds to
trans-piceid and peak 2 (retention time of 14.6 min) to trans-
resveratrol
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6, and 24 h. The reaction was stopped by adding methanol
at the ratio 2:1 (v/v) to the aliquots. Then, the samples were
centrifuged at 12,000g for 10 min (4 C) and filtered
through a 0.2 lm filter for the HPLC analysis.
Analytical method for monitoring the bioconversion
of piceid to resveratrol
Bioconversion of piceid to resveratrol was analyzed using
high-performance liquid chromatography (HPLC) using a
Dionex ICS 3000 HPLC, equipped with quaternary pump,
autosampler, and PDA-100 diode array detector, and con-
nected to Licrosphere RP C18 reverse-phase column
(250 mm 9 4.6 cm; particle size, 5 lm). Mobile phases
used for analysis were 10 % (v/v) MeOH in water (solvent
A) and 10 % (v/v) water in MeOH (solvent B), at a flow
rate 0.5 ml/min, with the following gradient: 0 min: 100 %
solvent A, 0–20 min: 0–90 % solvent B, 20–25 min:
90–60 % solvent B, 30 min: 60–0 % solvent B, followed
by 10 min equilibrium period with initial conditions prior
to the next sample injection (20 lL). Acquisitions of data
were performed using the Chromeleon software (Dionex,
Thermo Scientific, MA, USA) and a diode array detector
set at wavelengths of 280 and 306 nm. The identified peak
areas were compared with the calibration curve prepared
from the standard solutions in methanol (0–250 lM for
both standards). The calibration curves were prepared by
plotting the concentration of standard solutions (lM)
against the peak area. In this range of concentrations used,
the calibration curves were linear with the regression
coefficients R2 = 0.998.
Determination of anti-inflammatory activity
The potential anti-inflammatory effect was tested in murine
macrophages (RAW 264.7, ATCC-TIB-71) stimulated
with lipopolysaccharides (LPS). Cells were seeded at a
density of 2 9 106 cells per well in 12-well plates and
incubated for 24 h at 37 C. Cells were pretreated with test
substances in DMSO (\0.1 %) for 3 h at 37 C. Inflam-
mation was stimulated by adding LPS at a final concen-
tration of 1 lg/ml. After further 24 h of incubation at
37 C, the cell supernatant was collected and centrifuged at
15009g to remove cells.
The TNF-a, IL-6, and IL-10 secretion in the cell
supernatants were analyzed using enzyme-linked
immunosorbent assay (ELISA) assay according to the
manufacturer´s protocol (Bioscience, San Diego, CA, USA)
and using Infinite M200 microplate reader for measuring
optical density (Tecan, Crailsheim, Germany).
In parallel, the viability of the cells was tested using a
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide) tetrazolium reduction assay. The cells
were incubated in the presence of MTT for 2 h at 37 C.
The supernatant was then removed, and the cells were
lysed with a buffer-containing 10 % SDS in 0.01 N HCl.
The optical density at 570 nm, corrected by the reference
wavelength 690 nm (to reduce the background), was
determined.
The ELISA results were normalized to the MTT values
to reduce any variation from differences in cell density.
Concentrations with a viability reduction by 25 % or more
would be excluded due to cytotoxicity. Cells treated with
only LPS served as positive control and the resulting
amount of secreted cytokines was defined as 100 %. The
anti-inflammatory effect of dexamethasone, a known anti-
inflammatory agent, was tested in parallel.
Statistical analysis
All the experiments were done in triplicate in independent
experiments on different days. Statistical analysis was
performed using GraphPad Prism (GraphPad Software, San
Diego, USA) using one-way ANOVA, and Tukey’s test
cross comparing all study groups. Values of p\ 0.05 were
considered as significant.
Results
b-Glucosidase activity of Bifidobacterium spp.
and Lactobacillus spp.
b-Glucosidase activity of the cell extracts of Bifidobac-
terium spp. and Lactobacillus spp. was determined using
p-NPG as substrate and expressed in U/mg protein. As
shown in Table 1, B. infantis cell extract significantly
exerted the highest b-glucosidase activity among the pro-
biotics tested (17.4 U/mg, p\ 0.001). All other cell
extracts showed a lower, but still significant b-glucosidase
activity. No significant differences were observed of the
Table 1 b-Glucosidase activity of cell-free extracts of Lactobacillus
spp. and Bifidobacterium spp.
b-Glucosidase activitya
B. infantis 17.4 ± 0.5b
B. bifidum 0.6 ± 0.002c
L. plantarum 1.3 ± 0.008d
L. casei 1.5 ± 0.02d
L. acidophilus 1.6 ± 0.02d
a b-Glucosidase activity was expressed as units/mg protein. One unit
was defined as the amount of p-nitrophenol released from p-NPG
under the enzyme assay conditions, per ml per min
b–d Values (mean ± SD) with different superscript letters are sig-
nificantly different (p\ 0.05), n = 3
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enzyme activities between L. acidophilus, L. casei, and L.
plantarum, namely 1.6, 1.5, and 1.3 U/mg, respectively
(p[ 0.05). Bifidobacteria bifidum cell extract has signifi-
cantly shown the lowest b-glucosidase activity, namely 0.6
U/mg.
Conversion of piceid to resveratrol by selected
probiotic cell extracts
The ability of three cell extracts from Lactobacillus spp.
and two strains of Bifidobacterium spp. on the transfor-
mation of piceid to its bioactive aglycone resveratrol was
determined using HPLC (Fig. 1). All extracts significantly
deglycosylated piceid. However, large differences in the
yield and the rate of piceid bioconversion were observed.
B. infantis showed the highest enzyme activity toward
piceid, hydrolyzing 100 % of piceid to resveratrol within
30 min of incubation (Fig. 2a). Lactobacillus acidophilus,
L. plantarum, and L. casei cell-free extracts showed lower
conversion activity under the standard enzymatic condi-
tions (Fig. 2). During the first 30 min of incubation, no
significant differences were observed on the yield of con-
version within the three strains of Lactobacillus spp. and B.
bifidum (Fig. 2b). After 2 h of incubation, the yield of
hydrolysis was 21 % for L. acidophilus (Fig. 2c). No sig-
nificant differences were found for L. casei, showing a
yield of hydrolysis of 16 % (p[ 0.05) (Fig. 2d). After 2 h
of incubation, L. casei and L. acidophilus showed signifi-
cantly higher conversion yields in comparison with L.
plantarum (8 % p\ 0.01) (Fig. 2c–e). After 6 h of incu-
bation, the rate of hydrolysis for L. acidophilus was 47 %,
which was significantly higher (p\ 0.001) than that
observed for L. casei and L. plantarum, namely 36 and
26 %, respectively. After 24 h of incubation, piceid was
completely converted to resveratrol in the presence of L.
acidophilus enzymes. The rate of piceid hydrolysis by L.
casei and L. plantarum was significantly lower, namely 53
and 72 %, respectively. Bifidobacterium bifidum has shown
the lowest activity toward piceid among the probiotics
tested in this study with 32 % conversion yield (Fig. 2b).
During 24 h incubation of the control samples without cell
extract of a probiotic, piceid remained stable. Furthermore,
resveratrol was not further metabolized as observed at
HPLC chromatograms (Fig. 1).
Anti-inflammatory activity of resveratrol
Piceid showed no significant effect on the cytokine secre-
tion, whereas deglycosylation to resveratrol led to a sig-
nificant decrease of the secretion of the pro-inflammatory
cytokines IL-6 and TNFa, and an increase of the anti-in-
flammatory cytokine IL-10 (Fig. 3a). This effect was dose-
dependent (Fig. 3b).
Discussion
The deglycosylation of piceid to resveratrol from plant
sources is a crucial step to obtain sufficient bioavailability
and bioactivity. As elucidated in this study, cell extracts of
several probiotic strains, including B. infantis, B. bifidum,
L. acidophilus, L. casei, and L. plantarum efficiently con-
verted piceid to resveratrol. Among the probiotics tested,
the highest b-glucosidase activity was observed for B.
infantis. Differences in enzyme activity were shown for
different probiotics strains previously [19, 21]. According
to the best of our knowledge, this is the first study on the
ability of piceid conversion by cell extracts from Bifi-
dobacterium and Lactobacillus spp. However, the ability of
Bifidobacterium spp. to convert isoflavone-glycosides and
anthocyanine-glycoside was shown previously [19–21].
Since glycosidases are highly substrate specific, the
efficiency has to be evaluated for each polyphenol-glyco-
side. In this study, no significant differences were observed
in b-glucosidase activity toward the control substrate
p-NPG among Lactobacillus spp. in contrast to the sig-
nificant differences observed in piceid bioconversion. This
is in agreement with the previous studies which showed no
correlation between glucosidase activity and the yield of
daidzein formation from its glycosidic form [27]. The
probiotic b-glucosidase belongs to the group of glycosyl-
hydrolases, which can hydrolyse the glycosidic bond
between glucose moieties, present in gluco-oligosaccha-
rides and glycosylated molecules, and can exert different
specificities [28]. For the bifidobacteria tested, the gly-
colytic activity towards p-NPG correlated well with the
effect on the piceid bioconversion. In such a way, the cell-
free extract from B. infantis exerted the highest effect on
p-NPG and also on piceid, whereas the cell-free extract
from B. bifidum exerted the lowest effect on p-NPG and
also on piceid.
It has to be considered that only the enzymatic activity
of cell extracts was tested in this study. For using intact
probiotics or for an effect in the human gut, piceid has to be
diffusible through the cell membrane or the b-glucosidase
has to be an exo-enzyme. This may be analyzed in further
studies.
t-Resveratrol may be obtained from other sources as
well, such as plant cell culture [29] or recombinant bacteria
[30]. The level of resveratrol obtained from plant cell
culture or the recombinant bacteria is three times higher
than the level obtained with the lactobacilli. The level of
resveratrol obtained with B. infantis is comparable with the
level in the mentioned systems [29, 30].
For several diseases, it may be of importance to combine
probiotics with anti-inflammatory agents to obtain a syn-
ergistic effect. The gut microflora of patients with
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inflammatory bowel diseases (IBD) or related diseases (for
example) is changed to a lower number of Bifidobacterium
and Lactobacillus [31] and thus to a lower ß-glucosidase
activity by these strains. An alleviation of the symptoms of
irritable bowel syndrome and inflammatory bowel diseases
by probiotics could be shown [32, 33]. In addition,
resveratrol has shown to improve the gut microflora bal-
ance through increasing the number of bifidobacteria and
lactobacilli. However, there is a lack of studies on com-
parison of anti-inflammatory activities of piceid and
resveratrol which would be a great potential for further
investigations [34].
Fig. 2 Enzymatic hydrolysis of piceid (filled square) and formation
of resveratrol (open square) during incubation with cell-free extract
of a B. infantis, b B. bifidum c L. acidophilus, d L. casei, and e L.
plantarum at 37 C. The values of piceid and resveratrol are
expressed as percentage of the initial piceid concentration. During
24 h incubation of the control samples without cell extract of a
probiotic, piceid remained stable
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The results of this study lead to the suggestion that a
combined formulation of piceid and probiotics would be
advantageous. Piceid and probiotics may be incubated
before consumption to start already hydrolyzing piceid and
thus to obtain a more bioactive product. Furthermore, this
conversion may be continued in the human gut. On the
other hand, a colonization of the gut with these probiotic
strains may provide the possibility of a continuous bio-
transformation in the human gut.
Conclusion
Cell extracts of five different probiotic strains efficiently
deglycosylated piceid within 24 h. B. infantis has shown
the highest enzyme activity with complete bioconversion
of piceid into resveratrol within 30 min. The b-glucosidase
activity towards p-NPG cannot predict the activity towards
piceid. This study confirms the substrate specificity of
glycosyl-hydrolases from probiotics and, thus, the neces-
sity for evaluation of each strain separately. These
achievements open a new perspective for a combination of
probiotics and piceid in food products for increasing the
level of the health-promoting metabolite as resveratrol,
prior or after consumption. Furthermore, the combination
may be used as novel prodrug in pharmaceutical formula-
tions. Synergic effects of the anti-inflammatory activity of
resveratrol in combination with probiotics may be further
evaluated as of major interest for diseases with chronic
inflammation.
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